Overview
This course covers the mechanisms of action of drugs used to treat osteoporosis, including bisphosphonates, RANKL inhibitors, SERMs, PTH analogs, and sclerostin inhibitors. The goal is to understand how these medications promote bone health and prevent fractures. The course teaches how bisphosphonates inhibit bone resorption, RANKL inhibitors interfere with bone breakdown signaling, SERMs offer estrogen-like effects on bone density, PTH analogs stimulate bone formation, and sclerostin inhibitors increase bone density. The teaching method is through a comprehensive video lecture. The intended audience includes healthcare professionals, students, and individuals interested in osteoporosis treatment options.
Syllabus
Intro - Osteoclasts & Osteoblasts
Bone Remodeling Process
RANKL inhibitors
Bisphosphonates
Selective Estrogen Receptor Modulators
Parathyroid Hormone Analogs
Sclerostin Inhibitors
Summary
Taught by
Speed Pharmacology